Sustainability is Becoming the Standard in Pharma Manufacturing
Alex Del Priore – Senior Vice President, Manufacturing Services. The pressure to reduce environmental impact is reshaping how pharmaceutical companies approach manufacturing. Sustainability is no longer a secondary consideration. It is becoming a core design requirement, shaping how processes are developed, scaled, and evaluated across the industry. At the heart of this transition is green chemistry, which is evolving from an aspirational goal into a practical, business-critical tool.
Several forces are driving this shift. Fluctuating raw material costs, tightening solvent regulations, increasing scrutiny on waste generation, and the push for Scope 3 emissions reduction have converged. At the same time, the tools and frameworks available to support sustainable process redesign have matured significantly. What was once complex or experimental is now increasingly reliable, reproducible, and scalable in industrial settings.
We recently saw these changes come together in a project with a global pharmaceutical partner. The company